GO:0036041 long-chain fatty acid binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036041 (long-chain fatty acid binding) is a molecular function describing the selective, non-covalent binding of fatty acids with aliphatic tails of 13 to 22 carbons.
• Long-chain fatty acids (LCFAs) such as palmitate, oleate and arachidonate are central energy substrates, membrane building blocks and signaling molecules whose cellular fate depends on binding proteins.
• Dedicated fatty acid binding proteins (FABPs) and membrane-associated transport proteins mediate LCFA uptake, intracellular trafficking and nuclear delivery to transcription factors.
• LCFA binding influences nuclear receptor activity and gene transcription, linking lipid availability to metabolic gene programs.
• Dysregulated LCFA binding and trafficking contribute to lipotoxicity, metabolic disease, inflammation and cancer cell survival.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of LCFA-binding proteins in health and disease.
Description
Long-chain fatty acid binding (GO:0036041) is the molecular function of selectively and non-covalently interacting with a fatty acid that carries an aliphatic tail of 13 to 22 carbons. This function is executed by a large family of intracellular fatty acid binding proteins (FABPs) and by membrane-associated fatty-acid-binding/transport proteins that together govern how LCFAs are taken up, solubilized and routed within cells. Because LCFAs are hydrophobic and potentially detergent-like, their binding to proteins is not a passive event but a regulated step that determines whether these lipids are oxidized, esterified, stored or used as signals. For researchers, GO:0036041 matters because it sits at the intersection of energy metabolism, membrane biology and transcriptional control. LCFA binding proteins modulate nuclear receptors and gene transcription, thereby translating lipid availability into changes in gene expression. In parallel, LCFA binding and channeling influence mitochondrial fatty acid oxidation and cell survival, as shown by the interaction between anti-apoptotic MCL-1 and ACSL1 in promoting long-chain fatty acid oxidation. Consequently, the function is relevant to obesity, insulin resistance, cardiovascular disease, neuroinflammation and cancer. This article integrates the QuickGO definition of GO:0036041 with verified PubMed literature to summarize the mechanism, key genes, disease links and experimental strategies, including CRISPR-based models, for studying long-chain fatty acid binding.
long-chain fatty acid binding At A Glance
| GO ID | GO:0036041 |
|---|---|
| GO term | long-chain fatty acid binding |
| Ontology | molecular_function |
| Synonym | long chain fatty acid binding |
| Definition | Binding to a long-chain fatty acid; a long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. |
| Major function | Non-covalent recognition and solubilization of LCFAs for uptake, trafficking, oxidation, esterification or nuclear signaling. |
| Representative proteins | FABP family members (e.g., FABP3, FABP4, FABP5), membrane-associated transport proteins and ACSL1-associated complexes. |
| Cellular context | Cytosol, plasma membrane, mitochondria-associated membranes and nucleus. |
| Disease relevance | Lipotoxicity, metabolic syndrome, inflammation, neurodegeneration and cancer. |
What Is GO:0036041?
GO:0036041, long-chain fatty acid binding, is defined by the Gene Ontology as binding to a long-chain fatty acid, where a long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. In practice, this means the function is the reversible, non-covalent association of a protein with fatty acids such as myristate (C14), palmitate (C16), stearate (C18), oleate (C18:1) or arachidonate (C20:4). It is a molecular_function term and does not by itself imply catalysis, transport or signaling; rather, it describes the binding event that underlies these downstream processes.
Why Is long-chain fatty acid binding Important in Cell Biology?
Long-chain fatty acid binding is important because it determines the bioavailability and fate of the most abundant dietary and endogenous fatty acids. Proteins that execute GO:0036041 control whether LCFAs are oxidized for ATP, stored as triglycerides, incorporated into membranes or used as ligands for nuclear receptors. This function also protects cells from lipotoxicity by sequestering free LCFAs and their acyl-CoA derivatives. Because dysregulated LCFA handling is a hallmark of metabolic, inflammatory and neoplastic disease, understanding GO:0036041 is essential for mechanistic biology and therapeutic development.
• Controls cellular uptake and intracellular routing of dietary and endogenous long-chain fatty acids.
• Supports mitochondrial fatty acid oxidation and energy homeostasis.
• Modulates nuclear receptor activity and gene transcription in response to lipid availability.
• Protects against lipotoxicity by buffering free LCFAs and long-chain acylcarnitines.
• Contributes to inflammatory signaling, as shown for palmitic acid-induced S100B and TNF-alpha secretion.
• Influences cancer cell survival through LCFA oxidation pathways involving MCL-1 and ACSL1.
• Provides molecular targets for metabolic disease, neurodegeneration and cancer research.
• Enables CRISPR-based causal testing of FABP and transport protein function.
Molecular Mechanism of long-chain fatty acid binding
Substrate recognition and binding pocket
In simple terms: The protein has a pocket that fits long fatty acids and holds them loosely but specifically.
Long-chain fatty acid binding proteins typically use a beta-barrel or similar hydrophobic cavity to accommodate a 13-22 carbon aliphatic tail. Binding is non-covalent and reversible, allowing transfer of the ligand to membranes, enzymes or nuclear receptors. The selectivity for long-chain over short- or medium-chain fatty acids reflects the size and hydrophobicity of the binding cavity.
Cellular uptake and membrane-associated transport
In simple terms: Proteins at the cell surface help long-chain fatty acids get into the cell.
Membrane-associated fatty-acid-binding/transport proteins facilitate the cellular uptake of long-chain fatty acids, which are otherwise poorly soluble in aqueous environments. These proteins work with intracellular FABPs to create a soluble pool of LCFAs that can be metabolized or signaled. The uptake step is regulated and contributes to metabolic flexibility.
Intracellular trafficking and metabolic channeling
In simple terms: Inside the cell, binding proteins act like escorts that deliver fatty acids to the right place.
After binding, LCFAs are trafficked to mitochondria for beta-oxidation, to the endoplasmic reticulum for esterification, or to the nucleus for transcriptional regulation. ACSL1 and associated proteins channel LCFAs toward oxidation, and interaction with MCL-1 promotes long-chain fatty acid oxidation. This channeling prevents toxic accumulation of free fatty acids and acyl-CoAs.
Nuclear signaling and gene transcription
In simple terms: Some binding proteins carry fatty acids into the nucleus, where they influence which genes are turned on.
Fatty acid binding proteins and long-chain fatty acids modulate nuclear receptors and gene transcription, linking lipid status to expression programs. This function allows LCFAs to act as signaling molecules rather than only as fuel. The nuclear actions of LCFA-binding proteins are relevant to metabolic and inflammatory gene regulation.
Protection against lipotoxicity
In simple terms: Binding proteins keep dangerous fatty acid levels under control.
Heart-type fatty acid binding protein binds long-chain acylcarnitines and protects against lipotoxicity, illustrating a cytoprotective role of GO:0036041. By sequestering reactive lipid species, binding proteins reduce membrane damage and stress signaling. This protective function is important in tissues with high fatty acid flux, such as heart and muscle.
Key Genes Involved in GO:0036041 long-chain fatty acid binding
The following genes and proteins are representative executors or regulators of long-chain fatty acid binding (GO:0036041) and are frequently studied in metabolic, inflammatory and cancer research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FABP1 | Liver-type fatty acid binding protein; binds LCFAs and other lipids | Hepatic lipid metabolism and metabolic disease models |
| FABP2 | Intestinal fatty acid binding protein | Dietary fat absorption and intestinal metabolism |
| FABP3 | Heart-type fatty acid binding protein; binds long-chain acylcarnitines | Cardiac lipotoxicity and fatty acid oxidation |
| FABP4 | Adipocyte fatty acid binding protein | Adipose biology, insulin resistance and inflammation |
| FABP5 | Epidermal-type fatty acid binding protein | Lipid signaling and nuclear receptor regulation |
| FABP7 | Brain-type fatty acid binding protein | Neurodevelopment and brain lipid metabolism |
| FABP8 | Myelin fatty acid binding protein | Peripheral nerve myelin maintenance |
| FABP9 | Testis fatty acid binding protein | Male fertility and lipid metabolism |
| ACSL1 | Acyl-CoA synthetase that activates LCFAs for oxidation | LCFA oxidation and cancer cell survival |
| MCL-1 | Anti-apoptotic protein interacting with ACSL1 | Promotes long-chain fatty acid oxidation |
| CD36 | Membrane fatty acid translocase | LCFA uptake and metabolic signaling |
| SLC27A1 | Fatty acid transport protein 1 | Cellular LCFA uptake |
| SLC27A4 | Fatty acid transport protein 4 | LCFA uptake and skin barrier function |
| PPARA | Nuclear receptor activated by fatty acids | Transcriptional regulation of lipid metabolism |
| PPARD | Nuclear receptor responsive to LCFAs | Energy metabolism and gene transcription |
| NR1H3 | Liver X receptor alpha; modulated by lipid ligands | Cholesterol and fatty acid gene regulation |
| S100B | Astrocyte protein induced by palmitic acid | Neuroinflammation and LCFA signaling |
| TNF | Cytokine secreted in response to palmitic acid | Inflammatory signaling and lipotoxicity |
How Is long-chain fatty acid binding Regulated?
Long-chain fatty acid binding is regulated at multiple levels. The abundance of FABPs and transport proteins changes with metabolic state, and their expression is influenced by nuclear receptors that sense lipid ligands. Post-translational interactions, such as the binding of MCL-1 to ACSL1, can direct LCFAs toward oxidation and promote cell survival. In addition, the availability of specific LCFAs, including palmitic acid, can trigger inflammatory signaling that feeds back on lipid handling pathways. Together, these mechanisms tune GO:0036041 activity to cellular energy demand and stress.
long-chain fatty acid binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FABP3 | Cardiac lipotoxicity and metabolic stress | Knockout and overexpression in cardiomyocyte lines |
| ACSL1 | Cancer cell survival and LCFA oxidation | Knockout in cancer cell lines with MCL-1 interaction studies |
| S100B | Neuroinflammation induced by palmitic acid | Astrocyte cultures with point mutations in LCFA-binding proteins |
| FABP4 | Insulin resistance and adipose inflammation | Adipocyte knockout and knock-in models |
| CD36 | LCFA uptake in metabolic disease | Overexpression and knockout in hepatocyte or myocyte lines |
Metabolic and cardiovascular disease
Altered long-chain fatty acid binding and transport contribute to dyslipidemia, insulin resistance and cardiac lipotoxicity. Heart-type FABP binds long-chain acylcarnitines and protects against lipotoxicity, making it relevant to cardiac stress and metabolic disease. Regulation of energy metabolism by LCFAs further links this function to obesity and diabetes research.
Neuroinflammation and neurodegeneration
Palmitic acid, a long-chain saturated fatty acid, increases S100B protein and TNF-alpha secretion by astrocytes, implicating LCFA binding and signaling in neuroinflammation. Brain-type FABP and related proteins are studied for their roles in neuronal lipid metabolism and injury responses.
Cancer metabolism and survival
Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through interaction with ACSL1, linking LCFA handling to cancer cell survival. This connection makes GO:0036041 relevant to metabolic vulnerabilities in tumors.
Inflammatory and lipotoxic injury
Excess free LCFAs are toxic, and binding proteins protect cells by sequestering these lipids. When this buffering capacity is overwhelmed, inflammatory and stress pathways are activated, as seen with palmitic acid-induced cytokine secretion.
From long-chain fatty acid binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an FABP alter LCFA uptake or oxidation? | CRISPR knockout cell line |
| Does a specific binding-pocket residue control LCFA selectivity? | Point-mutation knock-in cell line |
| Can a tagged FABP report LCFA trafficking in live cells? | Tagged knock-in with fluorescent protein |
| Does overexpression of a transport protein increase LCFA flux? | Overexpression cell model |
| Does a disease-associated variant change LCFA binding? | Point-mutation knock-in and binding assays |
| Which genes are required for LCFA-dependent survival? | CRISPR library screening |
How to Study the long-chain fatty acid binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent fatty acid binding assay | Binding affinity and specificity for LCFAs | Characterizing FABP variants |
| Lipidomics | Cellular lipid species and acylcarnitines | Lipotoxicity and metabolic profiling |
| Seahorse respiration | Mitochondrial oxidation rates | LCFA-dependent energy metabolism |
| Isotope tracing | Flux of labeled fatty acids | Pathway analysis of LCFA oxidation |
| RNA-seq | Transcriptional responses to LCFAs | Nuclear receptor target gene discovery |
| Reporter assay | Nuclear receptor activity | PPAR/LXR regulation by LCFAs |
| Co-immunoprecipitation | Protein-protein interactions | ACSL1-MCL-1 complex studies |
| Live-cell imaging | Intracellular localization and trafficking | Tagged FABP dynamics |
Binding assays and lipidomics
Direct measurement of long-chain fatty acid binding can be performed with purified proteins or cell lysates using fluorescent fatty acid analogs and lipidomic profiling. These methods define the affinity and selectivity of proteins for LCFAs and their derivatives.
Metabolic flux analysis
Seahorse respiration, isotope tracing and fatty acid oxidation assays measure how LCFA binding proteins affect mitochondrial oxidation and energy metabolism. Such experiments link GO:0036041 to functional metabolic outcomes.
Transcriptomics and nuclear receptor reporter assays
RNA-seq and luciferase reporter assays for PPAR and LXR family receptors assess how LCFA binding modulates gene transcription. These approaches connect lipid binding to downstream expression programs.
Imaging and protein interaction studies
Fluorescence microscopy of tagged FABPs and co-immunoprecipitation can reveal intracellular trafficking and interactions such as ACSL1-MCL-1. These methods localize LCFA binding events within cells.
How CRISPR Can Be Used to Study GO:0036041 long-chain fatty acid binding
Knockout
CRISPR knockout of FABP or transport genes removes long-chain fatty acid binding activity, allowing researchers to test its requirement for LCFA uptake, oxidation and cell survival. Knockout models are foundational for causal inference in metabolic studies.
Point Mutation
Point mutations in the ligand-binding pocket can selectively disrupt LCFA binding without deleting the protein, revealing which functions depend on GO:0036041. Such models are useful for separating binding from scaffolding roles.
Knock-in
Knock-in of tagged or disease-associated variants enables tracking of LCFA binding proteins and testing of patient-relevant mutations. Fluorescent or affinity tags support imaging and interaction studies.
Overexpression
Overexpression of FABPs or transport proteins increases LCFA binding capacity and can drive metabolic or inflammatory phenotypes. These models help define sufficiency of a given protein for LCFA handling.
How EDITGENE Supports long-chain fatty acid binding Research
Researchers studying long-chain fatty acid binding-related genes often need to determine whether a candidate gene is causally involved in LCFA uptake, trafficking, oxidation or signaling. EDITGENE provides CRISPR-based cell models and screening services that enable precise, reproducible interrogation of GO:0036041 in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for long-chain fatty acid binding research.
Frequently Asked Questions About long-chain fatty acid binding
What is long-chain fatty acid binding?
Long-chain fatty acid binding (GO:0036041) is the molecular function of non-covalently binding fatty acids with aliphatic tails of 13 to 22 carbons, such as palmitate and oleate.
What genes are involved in long-chain fatty acid binding?
Key genes include FABP family members (FABP1-FABP9), ACSL1, CD36 and SLC27A transporters, which mediate LCFA recognition, uptake and trafficking.
What is the GO ID for long-chain fatty acid binding?
The Gene Ontology ID is GO:0036041, a molecular_function term.
How do long-chain fatty acids enter cells?
Membrane-associated fatty-acid-binding/transport proteins facilitate LCFA uptake, working with intracellular FABPs to solubilize and route these lipids.
Why is long-chain fatty acid binding important in cancer?
LCFA oxidation promoted by MCL-1 and ACSL1 supports cancer cell survival, making LCFA binding and trafficking relevant to tumor metabolism.
Can long-chain fatty acids regulate gene expression?
Yes, fatty acid binding proteins and LCFAs modulate nuclear receptors and gene transcription, linking lipid status to expression programs.
What diseases are linked to long-chain fatty acid binding?
Metabolic and cardiovascular disease, neuroinflammation, lipotoxicity and cancer have been linked to altered LCFA binding and trafficking.
How can I study long-chain fatty acid binding with CRISPR?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of LCFA-binding proteins in uptake, oxidation and signaling assays.
What is the difference between short-chain and long-chain fatty acid binding?
Long-chain fatty acids have 13-22 carbons, whereas short- and medium-chain fatty acids are shorter and handled by different metabolic routes.
What methods measure long-chain fatty acid binding?
Fluorescent fatty acid binding assays, lipidomics, isotope tracing, Seahorse respiration and reporter assays are commonly used.
Conclusion
GO:0036041, long-chain fatty acid binding, is a central molecular function that governs how cells recognize, solubilize and route fatty acids of 13 to 22 carbons. Through FABPs, ACSL1, CD36 and transport proteins, this function connects lipid availability to energy metabolism, nuclear receptor signaling and cell survival. Dysregulation of LCFA binding contributes to metabolic disease, neuroinflammation and cancer, making it a high-value target for mechanistic and therapeutic research. CRISPR-based knockout, point-mutation, knock-in, overexpression and library screening approaches provide rigorous tools to dissect GO:0036041 in relevant cell models. EDITGENE supports these efforts with custom cell model generation and bioinformatics, helping researchers translate lipid-binding biology into actionable discoveries.
References
- 1. Nakamura MT et al.. 2014. Regulation of energy metabolism by long-chain fatty acids.. Prog Lipid Res 53:124-44 PMID: 24362249
- 2. Wright T et al.. 2024. Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through interaction with ACSL1.. Mol Cell 84(7):1338-1353.e8 PMID: 38503284
- 3. Schönfeld P et al.. 2016. Short- and medium-chain fatty acids in energy metabolism: the cellular perspective.. J Lipid Res 57(6):943-54 PMID: 27080715
- 4. Dutta-Roy AK. 2000. Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins.. Cell Mol Life Sci 57(10):1360-72 PMID: 11078015
- 5. Schroeder F et al.. 2008. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.. Lipids 43(1):1-17 PMID: 17882463
- 6. Fróes FT et al.. 2024. Palmitic acid, but not other long-chain saturated fatty acids, increases S100B protein and TNF-α secretion by astrocytes.. Nutr Res 122:101-112 PMID: 38215571
- 7. Zelencova-Gopejenko D et al.. 2023. Heart-Type Fatty Acid Binding Protein Binds Long-Chain Acylcarnitines and Protects against Lipotoxicity.. Int J Mol Sci 24(6) PMID: 36982599
- 8. He Q et al.. 2023. Cellular Uptake, Metabolism and Sensing of Long-Chain Fatty Acids.. Front Biosci (Landmark Ed) 28(1):10 PMID: 36722264
